6533b828fe1ef96bd128828c

RESEARCH PRODUCT

IgG1 antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency

Domenico LioAlessandro VenturaA PicarelliV MarinoCorazza Gino RobertoFrancesco Cataldo

subject

Screening testbiologyTissue transglutaminaseGastroenterologySelective IgA deficiencymedicine.diseaseEndomysiumCoeliac diseaseAntiendomysium antibodiesmedicine.anatomical_structureImmunopathologyImmunologymedicinebiology.proteinAntibody

description

Background—In selective IgA deficiency (IgAD), there is no reliable screening test for coeliac disease (CD). Aim—To evaluate the usefulness of IgG1 antiendomysium and IgG antitissue transglutaminase tests for CD diagnosis in IgAD. Methods—IgA and IgG antigliadin antibodies (IgA- and IgG-AGA), IgA and IgG1 antiendomysium antibodies (IgA- and IgG1-EMA), and IgA and IgG antitissue

yearjournalcountryeditionlanguage
2000-09-01Gut
https://doi.org/10.1136/gut.47.3.366